Company: SUPN
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001356576-25-000033
Chunk: 48

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-05-06
Form: 10-Q
Item: Part I, Item 1
Chunk 48
---
 2025 (unaudited)177,720$27.43 20,000$28.63 197,720$27.55 

10.    Earnings (Loss) per Share

The following table sets forth the computation of basic and diluted earnings (loss) per share for the three months ended March 31, 2025 and 2024 (dollars in thousands, except share and per share amounts):Three Months EndedMarch 31,20252024(unaudited)Numerator:Net earnings (loss)$(11,827)$124 Denominator:Weighted average shares outstanding, basic55,864,692 54,801,748 Effect of dilutive securities:Stock options and stock awards— 824,915 Weighted average shares outstanding, diluted55,864,692 55,626,663 Earnings (Loss) per share, basic$(0.21)$0.00 Earnings (Loss) per share, diluted$(0.21)$0.00 The following table sets forth the common stock equivalents of outstanding stock-based awards excluded in the calculation of diluted earnings (loss) per share, because their inclusion would be anti-dilutive:Three Months EndedMarch 31,20252024(unaudited)Stock options and stock awards505,385 520,152 

11.    Income Tax Expense 

The following table provides information regarding the Company’s income tax expense for the three months ended March 31, 2025 and 2024 (dollars in thousands):Three Months EndedMarch 31,20252024(unaudited)Income tax expense$5,996 $119 Effective tax rate(102.8)%49.0 %Income tax expense was $6.0 million ((102.8)% effective tax rate) for the three months ended March 31, 2025, as compared to an income tax expense of $0.1 million (49.0% effective tax rate) for the three months ended March 31, 2024. The 

16

change was primarily due to near break-even pre-tax losses on both the three months ended March 31, 2025 and full year 2025 forecast as compared to the same periods in 2024. The Company's effective income tax rate for the three months ended March 31, 2025 varies from the statutory federal tax rate in United States (U.S. federal tax rate) of 21%